Author
Listed:
- Vishal Khairnar
(University Hospital Essen)
- Vikas Duhan
(University Hospital Essen)
- Ashwini M. Patil
(University Hospital Essen)
- Fan Zhou
(University Hospital Essen)
- Hilal Bhat
(University Hospital Essen)
- Christine Thoens
(Heinrich-Heine-University)
- Piyush Sharma
(University Hospital Essen)
- Tom Adomati
(University Hospital Essen)
- Sarah-Kim Friendrich
(University Hospital Essen)
- Judith Bezgovsek
(University Hospital Essen)
- Janine D. Dreesen
(University Hospital Essen)
- Gunther Wennemuth
(University Hospital Essen)
- Astrid M. Westendorf
(University Hospital Essen)
- Gennadiy Zelinskyy
(University Hospital Essen)
- Ulf Dittmer
(University Hospital Essen)
- Cornelia Hardt
(University Hospital Essen)
- Jörg Timm
(Heinrich-Heine-University)
- Joachim R. Göthert
(University Hospital Essen)
- Philipp A. Lang
(Heinrich-Heine-University
Medical Faculty, Heinrich-Heine-University)
- Bernhard B. Singer
(University Hospital Essen)
- Karl S. Lang
(University Hospital Essen
Heinrich-Heine-University)
Abstract
Dysfunction of CD8+ T cells can lead to the development of chronic viral infection. Identifying mechanisms responsible for such T cell dysfunction is therefore of great importance to understand how to prevent persistent viral infection. Here we show using lymphocytic choriomeningitis virus (LCMV) infection that carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is fundamental for recruiting lymphocyte-specific protein kinase (Lck) into the T cell receptor complex to form an efficient immunological synapse. CEACAM1 is essential for activation of CD8+ T cells, and the absence of CEACAM1 on virus-specific CD8+ T cells limits the antiviral CD8+ T cell response. Treatment with anti-CEACAM1 antibody stabilizes Lck in the immunological synapse, prevents CD8+ T cell exhaustion, and improves control of virus infection in vivo. Treatment of human virus-specific CD8+ T cells with anti-CEACAM1 antibody similarly enhances their proliferation. We conclude that CEACAM1 is an important regulator of virus-specific CD8+ T cell functions in mice and humans and represents a promising therapeutic target for modulating CD8+ T cells.
Suggested Citation
Vishal Khairnar & Vikas Duhan & Ashwini M. Patil & Fan Zhou & Hilal Bhat & Christine Thoens & Piyush Sharma & Tom Adomati & Sarah-Kim Friendrich & Judith Bezgovsek & Janine D. Dreesen & Gunther Wennem, 2018.
"CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection,"
Nature Communications, Nature, vol. 9(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04832-2
DOI: 10.1038/s41467-018-04832-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04832-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.